EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CPIX: Cumberland Pharmaceu

27 Oct 25 13:02
LAST:

3.450

CHANGE:
 0.04		OPEN:
3.530		HIGH:
3.530		ASK:
12.000		VOLUME:
7.0K
CHG(%):
1.15		PREV:
3.490		LOW:
3.440		BID:
0.310		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
27 Oct 253.5303.5303.4403.4507.0K
24 Oct 253.5403.5403.4303.49011.9K
23 Oct 253.4603.5103.4053.51020.5K
22 Oct 253.6503.6503.4203.46030.5K
21 Oct 253.6103.6773.5203.64027.3K
20 Oct 253.4003.6803.3653.56054.5K
17 Oct 253.4503.5553.3703.44013.6K
16 Oct 253.4403.5203.4003.45022.4K
15 Oct 253.3803.4503.3003.44031.6K
14 Oct 253.4803.4803.2903.38022.3K

COMPANY PROFILE

Name:Cumberland Pharmaceu
About:Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiting for patients receiving chemotherapy treatment; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of the cardiomyopathy associate with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, and aspirin-exacerbated respiratory disease; and is in Phase II clinical trial for the treatment of systemic sclerosis and idiopathic pulmonary fibrosis. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Sector:Healthcare
Address:1600 West End Avenue, Nashville, TN, United States, 37203
Website:https://www.cumberlandpharma.com
CUSIP:230770109
CIK:0001087294
ISIN:US2307701092
FIGI:BBG000R93GV7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:3.511.7%
MA10:3.480.9%
MA20:3.411.3%
MA50:3.353.1%
MA100:3.563.2%
MA200:4.0718.0%
STO9:4.17 
STO14:27.41
RSI14:44.60
WPR14:-71.34
MTM14:-0.22
ROC14:-0.06 
ATR:0.19 
Week High:3.686.7%
Week Low:3.372.5%
Month High:3.696.9%
Month Low:3.0318.0%
Year High:7.25110.1%
Year Low:1.04231.7%
Volatility:35.94